Starpharma Holdings Ltd (SPL) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Starpharma Holdings Ltd (SPL) has a cash flow conversion efficiency ratio of 0.182x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$3.91 Million ≈ $2.77 Million USD) by net assets (AU$21.48 Million ≈ $15.20 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See SPL days of operational coverage to measure how many days the company can operate on defensive assets alone.
Starpharma Holdings Ltd - Cash Flow Conversion Efficiency Trend (2001–2025)
This chart illustrates how Starpharma Holdings Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Starpharma Holdings Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Starpharma Holdings Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
UNISEM Co. Ltd
KQ:036200
|
0.022x |
|
Goknur Gida Maddeleri Enerji Imalati Ithalat Ihracat Ticaret ve Sanayi A.S.
IS:GOKNR
|
0.004x |
|
BVZ Holding AG
SW:BVZN
|
0.079x |
|
HMS Bergbau AG
XETRA:HMU
|
-0.399x |
|
Chicago Atlantic BDC, Inc.
NASDAQ:LIEN
|
0.000x |
|
Xiwang Foodstuffs Co Ltd
SHE:000639
|
0.057x |
|
Bank Amar Indonesia
JK:AMAR
|
0.022x |
|
Voyager Therapeutics Inc
NASDAQ:VYGR
|
-0.141x |
Annual Cash Flow Conversion Efficiency for Starpharma Holdings Ltd (2001–2025)
The table below shows the annual cash flow conversion efficiency of Starpharma Holdings Ltd from 2001 to 2025. For the full company profile with market capitalisation and key ratios, see Starpharma Holdings Ltd market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$19.00 Million ≈ $13.44 Million |
AU$-6.76 Million ≈ $-4.78 Million |
-0.356x | -43.37% |
| 2024-06-30 | AU$28.12 Million ≈ $19.89 Million |
AU$-6.98 Million ≈ $-4.94 Million |
-0.248x | +36.16% |
| 2023-06-30 | AU$34.81 Million ≈ $24.63 Million |
AU$-13.53 Million ≈ $-9.58 Million |
-0.389x | -42.92% |
| 2022-06-30 | AU$48.39 Million ≈ $34.24 Million |
AU$-13.16 Million ≈ $-9.31 Million |
-0.272x | -14.43% |
| 2021-06-30 | AU$62.30 Million ≈ $44.08 Million |
AU$-14.81 Million ≈ $-10.48 Million |
-0.238x | +30.90% |
| 2020-06-30 | AU$31.33 Million ≈ $22.17 Million |
AU$-10.78 Million ≈ $-7.62 Million |
-0.344x | -40.99% |
| 2019-06-30 | AU$42.40 Million ≈ $30.00 Million |
AU$-10.34 Million ≈ $-7.32 Million |
-0.244x | -27.43% |
| 2018-06-30 | AU$53.28 Million ≈ $37.70 Million |
AU$-10.20 Million ≈ $-7.22 Million |
-0.191x | +31.13% |
| 2017-06-30 | AU$60.98 Million ≈ $43.15 Million |
AU$-16.95 Million ≈ $-12.00 Million |
-0.278x | +22.85% |
| 2016-06-30 | AU$49.42 Million ≈ $34.97 Million |
AU$-17.81 Million ≈ $-12.60 Million |
-0.360x | +0.59% |
| 2015-06-30 | AU$37.56 Million ≈ $26.57 Million |
AU$-13.62 Million ≈ $-9.63 Million |
-0.363x | -21.73% |
| 2014-06-30 | AU$32.95 Million ≈ $23.31 Million |
AU$-9.81 Million ≈ $-6.94 Million |
-0.298x | -39.76% |
| 2013-06-30 | AU$45.97 Million ≈ $32.53 Million |
AU$-9.79 Million ≈ $-6.93 Million |
-0.213x | -6.11% |
| 2012-06-30 | AU$48.65 Million ≈ $34.42 Million |
AU$-9.77 Million ≈ $-6.91 Million |
-0.201x | +14.13% |
| 2011-06-30 | AU$27.69 Million ≈ $19.59 Million |
AU$-6.48 Million ≈ $-4.58 Million |
-0.234x | -124.47% |
| 2010-06-30 | AU$34.84 Million ≈ $24.65 Million |
AU$-3.63 Million ≈ $-2.57 Million |
-0.104x | +34.07% |
| 2009-06-30 | AU$25.50 Million ≈ $18.04 Million |
AU$-4.03 Million ≈ $-2.85 Million |
-0.158x | +39.82% |
| 2008-06-30 | AU$20.38 Million ≈ $14.42 Million |
AU$-5.35 Million ≈ $-3.79 Million |
-0.263x | -99.82% |
| 2007-06-30 | AU$25.72 Million ≈ $18.20 Million |
AU$-3.38 Million ≈ $-2.39 Million |
-0.131x | +62.60% |
| 2006-06-30 | AU$21.32 Million ≈ $15.08 Million |
AU$-7.49 Million ≈ $-5.30 Million |
-0.351x | +39.71% |
| 2005-06-30 | AU$9.97 Million ≈ $7.05 Million |
AU$-5.81 Million ≈ $-4.11 Million |
-0.583x | -76.57% |
| 2004-06-30 | AU$17.59 Million ≈ $12.45 Million |
AU$-5.81 Million ≈ $-4.11 Million |
-0.330x | +22.04% |
| 2002-06-30 | AU$17.27 Million ≈ $12.22 Million |
AU$-7.31 Million ≈ $-5.17 Million |
-0.423x | -329.93% |
| 2001-06-30 | AU$24.92 Million ≈ $17.63 Million |
AU$-2.45 Million ≈ $-1.74 Million |
-0.098x | -- |
About Starpharma Holdings Ltd
Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development and commercialization of dendrimer technology for pharmaceutical, healthcare applications, life science, and other applications in Australia and internationally. The company's products include VivaGel BV, a non-antibiotic vaginal gel for the treatment of bacterial vaginosis (BV) and prevention of recurr… Read more